{"vid":"V112","name":"druge","file_id":"F1","var_intrvl":"discrete","var_width":"62","var_respunit":"Patients with type 2 diabetes being interviewed.","var_qstn_preqtxt":"Medications \nHas this changed in [COVID] period = the time you were most affected [if applicable]","var_qstn_qstnlit":"N\/A","var_qstn_postqtxt":"N\/A","var_qstn_ivulnstr":"N\/A","var_universe":"Patients with type 2 diabetes","universe_clusion":"I","var_sumstat":[{"value":"94","type":"vald"},{"value":"0","type":"invd"}],"var_txt":"N\/A","var_catgry":[{"value":"(a) Insulin only","labl":null,"stats":"20","type":"freq"},{"value":"(c) Both insulin + Oral Hypoglycaemic","labl":null,"stats":"6","type":"freq"},{"value":"b) Oral Hypoglycaemic drug only (e.g Metformin, Glibenclamide)","labl":null,"stats":"68","type":"freq"}],"var_format":"character","var_format_schema":"other","fid":"F1","sid":"175","survey_idno":"DDI-KEN-APHRC-GEGO-2021-v1.0"}